| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Biochemistry, University of Medicine and Dentistry of New Jersey-New Jersey, Medical School, Graduate School of Biomedical Sciences Newark, New Jersey 07103
Experimental Pathology Group, Los Alamos National Laboratory Los Alamos, New Mexico 87545
Address requests for reprints to: Sylvia Christakos, Ph.D., Department of Biochemistry, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, 185 South Orange Avenue, Newark, New Jersey 07103-2757.
Abstract
To determine whether 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] regulates transcription of the rat renal calbindin-D28k gene, the rate of calbindin-D28k mRNA synthesis was measured directly in nuclei using the in vitro nuclear transcription assay. Nuclei were prepared from kidneys of vitamin D-deficient rats at various times after a single ip injection of 1,25-(OH)2D3, and transcription was allowed to proceed in vitro in the presence of [32P]UTP for 30 min at 29 C, at which time the incorporation of UTP into trichloroacetic acid-precipitable material was optimal. Incorporation of UTP was decreased by 64.6% by
-amanitin, which selectively inhibits polymerase II. Purified [32P]RNA was analyzed for newly synthesized calbindin-D-28k gene transcripts by hybridization to calbindin-D-28k cDNA immobilized on nitrocellulose filters. Using this assay we found that the first significant increase in calbindin-D28k gene transcription occurred at 1 h, and the peak of transcriptional activity occurred at 2 h. Within 12 h of 1,25-(OH)2D3 treatment, calbindin-D28k gene transcription returned to control levels. Using Northern blot analysis, a significant increase in calbindin-D RNA was first observed 2h after hormone administration, reaching a maximum at 12 h. Renal calbindin-D28k protein levels are significantly increased by 3 h and reach a maximum value 48 h after hormone administration. Our results suggest that the early increase in renal calbindin-D28k may be due to transcriptional regulation. The long time lag between transcription and the peak of calbindin mRNA and calbindin protein accumulation may reflect the involvement of post-transcriptional mechanisms. These findings indicate that renal calbindin-D28k, similar to other steroidinduced proteins, is regulated by hormone at the transcriptional and posttranscriptional levels. The calbindin-D28k cDNA was also used to assign the corresponding human gene to chromosome 8 from data obtained by hybridization of the calbindin probe to spots of individual human chromosomes that were flow sorted onto nitrocellulose filters. Results of Southern blot analysis are consistent with a single calbindin gene in the human genome.
FOOTNOTES
This work was supported in part by NIH Grants DK-38961 and NS20270 (to S.C.).
Received for publication October 10, 1988. Revision received December 12, 1988. Accepted for publication December 12, 1988.
This article has been cited by other articles:
![]() |
W. Zheng, Y. Xie, G. Li, J. Kong, J. Q. Feng, and Y. C. Li Critical Role of Calbindin-D28k in Calcium Homeostasis Revealed by Mice Lacking Both Vitamin D Receptor and Calbindin-D28k J. Biol. Chem., December 10, 2004; 279(50): 52406 - 52413. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. C. Li, M. J. G. Bolt, L.-P. Cao, and M. D. Sitrin Effects of vitamin D receptor inactivation on the expression of calbindins and calcium metabolism Am J Physiol Endocrinol Metab, September 1, 2001; 281(3): E558 - E564. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Raval-Pandya, L. P. Freedman, H. Li, and S. Christakos Thyroid Hormone Receptor Does Not Heterodimerize with the Vitamin D Receptor but Represses Vitamin D Receptor-Mediated Transactivation Mol. Endocrinol., September 1, 1998; 12(9): 1367 - 1379. [Abstract] [Full Text] |
||||
![]() |
Y. C. Li, A. E. Pirro, and M. B. Demay Analysis of Vitamin D-Dependent Calcium-Binding Protein Messenger Ribonucleic Acid Expression in Mice Lacking the Vitamin D Receptor Endocrinology, March 1, 1998; 139(3): 847 - 851. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |